Study of Alfimeprase to Rapidly Dissolve Blood Clots in the Leg and Help Prevent the Need for Surgery on Leg Arteries

PHASE3CompletedINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

April 30, 2005

Primary Completion Date

February 28, 2007

Study Completion Date

February 28, 2007

Conditions
Arterial Occlusive Diseases
Interventions
DRUG

alfimeprase

Trial Locations (1)

Unknown

The Cleveland Clinic Foundation, Cleveland

Sponsors
All Listed Sponsors
lead

ARCA Biopharma, Inc.

INDUSTRY